High materiality7/10
Eli Lilly price target raised to $1,419 from $1,347 at Morgan Stanley
Why it may matterVerify against the original reporting
Bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises target to $1,419 vs price $1,170; implied upside ~21%.
- Morgan Stanley target $1,419 vs price $1,170; ~21% upside.
Key facts
- 01
Target: $1,419
- 02
Posted price: $1,170
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.